Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEPOLIZUMAB vs MEROPENEM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEPOLIZUMAB vs MEROPENEM: Safety Overview

Metric MEPOLIZUMAB MEROPENEM
Total FAERS Reports 43,006 13,867
Deaths Reported 3,158 3,880
Death Rate 7.3% 28.0%
Hospitalizations 13,819 7,167
Average Patient Age 58.9 yrs 51.1 yrs
% Female Patients 67.1% 42.9%
FDA Approval Date N/A Apr 12, 2016
Manufacturer GlaxoSmithKline LLC Eugia US LLC
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Discontinued